R&D | April 16, 2026
INST scientists develop glowing nanosensor for rapid nicotine, cotinine detection
he innovation could pave the way for early and low-cost screening of smoking exposure and second-hand smoke biomarkers
he innovation could pave the way for early and low-cost screening of smoking exposure and second-hand smoke biomarkers
The collaboration combines Alveus’ expertise in metabolic biology and therapeutic strategy with Aurigene’s integrated discovery capabilities
The goal is to better support drug developers as programs move from laboratory research into clinical trials
Paves the way for next-gen ultra-precise gas sensing
The partnership aims to fuse antibody-drug conjugation (ADC) technology with targeted protein degradation
For the biopharma industry, the study strengthens the case for balancing immune-cell engagement with tolerability in antibody discovery platforms
Biopharma companies face persistent hurdles in cell line development, including long timelines, low yields, and high failure rates for novel molecules
Under the collaboration, Symeres will test Ambagon’s newly designed molecular glues using in vitro assays and mechanistic studies
Multi-year CDMO partnership combines AI-led virtual development, precision chemistry and GMP manufacturing to accelerate five high-science APIs across regulated markets
They also differentiated the innovator biologic Semaglutide molecule from newer synthetic or chemical generic versions entering the market
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
